Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Alcohol Clin Exp Res ; 43(5): 988-996, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-30973651

RESUMEN

BACKGROUND: Alcohol-induced blackouts, a form of anterograde amnesia that restricts the encoding of short-term memories into long-term ones, are among the most severe alcohol-related consequences. College students are at high risk of experiencing alcohol-induced blackouts, and there is a need to determine whether alcohol interventions can effectively reduce blackouts in this population. The current study uses data from 3 randomized clinical trials to examine the effect of various intervention approaches on alcohol-induced blackouts. METHODS: Four interventions were compared over 3 studies: (i) a computerized feedback intervention (electronic Check-Up To Go [e-Chug]; Study 1); (ii) a single-session brief motivational intervention (BMI; Study 1); (iii) a BMI plus behavioral economic session focused on increasing substance-free activities (BMI + Substance-Free Activity Session [SFAS]; Studies 2 and 3); and (iv) a BMI plus supplemental Relaxation Training session (BMI + Relaxation Training; Studies 2 and 3). Studies 1 and 3 also included an assessment-only control condition. For each study, participants reported whether they had experienced an alcohol-induced blackout at each time point; binary logistic regressions examined differential likelihood of experiencing an alcohol-induced blackout over time. RESULTS: Neither the single-session BMI nor e-Chug reduced alcohol-induced blackouts over assessment only; however, participants in the BMI + SFAS or BMI + Relaxation Training condition were significantly less likely to experience an alcohol-induced blackout compared to assessment only at 1-month (Wald = 4.77, odds ratio [OR] = 0.53, p = 0.03) and 6-month follow-ups (Wald = 5.72, OR = 0.52, p = 0.02). Study 2 also revealed a larger effect for the BMI + SFAS over the BMI + Relaxation Training condition at 6 months (Wald = 4.11 OR = 0.22, p = 0.043), although this was not replicated in Study 3. The effects for the 2-session BMIs lasted 6 months, at which point maturation effects diminished differences between assessment-only and intervention conditions. CONCLUSIONS: Two sessions of BMI are a substantial enough dose to result in reductions in alcohol-induced blackouts among college student heavy drinkers.


Asunto(s)
Consumo de Alcohol en la Universidad/psicología , Intoxicación Alcohólica/psicología , Intoxicación Alcohólica/terapia , Entrevista Motivacional/tendencias , Adolescente , Intoxicación Alcohólica/epidemiología , Amnesia Anterógrada/epidemiología , Amnesia Anterógrada/prevención & control , Amnesia Anterógrada/psicología , Femenino , Estudios de Seguimiento , Humanos , Masculino , Motivación/fisiología , Entrevista Motivacional/métodos , Ensayos Clínicos Controlados Aleatorios como Asunto/métodos , Adulto Joven
2.
J ECT ; 29(3): 170-8, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23519225

RESUMEN

BACKGROUND: Electroconvulsive therapy (ECT) continues to be an effective treatment option for patients who fail to respond to pharmacological interventions, are unable to tolerate medications, and show a suboptimal response to behavioral and psychotherapeutic treatments. However, risks for cognitive impairment may contribute to some patients' refusal of ECT. METHODS: The present study examined galantamine as a pharmacological intervention to reduce cognitive adverse effects from ECT. Thirty-nine inpatients diagnosed with major depressive disorder; bipolar disorder, depressed type; or schizoaffective disorder, depressed type and admitted for ECT were randomized to galantamine or placebo. Study drugs were initiated 24 to 48 hours before starting ECT and continued throughout the course of ECT. A neuropsychological test battery was administered at baseline and 24 to 48 hours after completing a course of ECT treatments. Depression severity was monitored using the 17-item Hamilton Rating Scale for Depression and Clinical Global Impression Scale at baseline, weekly, and end point. Self-rated adverse effects were monitored weekly. RESULTS: Thirty participants (12 patients in the galantamine group, 18 patients in the placebo group) had both pretreatment and posttreatment neuropsychological ratings. Those in the galantamine group scored significantly higher at discharge for delayed memory (t28 = 2.44, P < 0.05). Hierarchical regressions examined if treatment condition predicted changes in delayed memory scores from baseline to discharge. Inclusion of the treatment condition in the final model made a significant incremental improvement in prediction (ΔR = 0.12, F1,27 change = 4.65, P < 0.05; ß = 0.37, t = 2.16, P < 0.05). Galantamine was well tolerated with no clinically significant bradycardia or prolonged paralysis when administered with ECT. CONCLUSIONS: Galantamine may be protective against impairment in retention of new learning. Galantamine exhibited minimal adverse effects and was safe when administered during ECT. The present findings require replication by future researchers using larger samples before broad conclusions can be drawn.


Asunto(s)
Amnesia Anterógrada/etiología , Amnesia Anterógrada/prevención & control , Terapia Electroconvulsiva/efectos adversos , Galantamina/uso terapéutico , Nootrópicos/uso terapéutico , Afecto/fisiología , Cognición/fisiología , Estudios de Cohortes , Trastorno Depresivo Mayor/psicología , Trastorno Depresivo Mayor/terapia , Método Doble Ciego , Femenino , Galantamina/efectos adversos , Humanos , Pacientes Internos , Masculino , Persona de Mediana Edad , Pruebas Neuropsicológicas , Nootrópicos/efectos adversos , Escalas de Valoración Psiquiátrica , Trastornos Psicóticos/psicología , Trastornos Psicóticos/terapia
3.
Pharm Biol ; 48(2): 234-40, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20645848

RESUMEN

CONTEXT: Ficus religiosa Linn (Moraceae) is a variety of fig tree. Its figs are known to contain a high serotonergic content, and modulation of serotonergic neurotransmission plays a crucial role in the pathogenesis of amnesia. Thus, the present study was envisaged. OBJECTIVE: To investigate the effect of the methanol extract of figs of Ficus religiosa (FRFE) on scopolamine-induced anterograde and retrograde amnesia in mice. MATERIALS AND METHODS: Transfer latency (TL) to the preferred niche in the elevated plus-maze (EPM) and learning avoidance of passive behavior to avoid punishment in the modified passive avoidance paradigm (MPA) served as behavioral models for the assessment of memory. Scopolamine (1 mg/kg, i.p.) was administered before training for induction of anterograde amnesia and before retrieval for induction of retrograde amnesia in both models. TL in the EPM, step down latency (SDL), number of trials, and number of mistakes in the MPA were determined in vehicle control, FRFE treated (10, 50, and 100 mg/kg, i.p.), and standard groups (piracetam 200 mg/kg, i.p.). Cyproheptadine, a non-selective 5-HT(1/2) blocker (4 mg/kg, i.p.), was administered along with the FRFE to investigate the involvement of serotonergic pathways in the anti-amnesic effect of FRFE. RESULTS AND DISCUSSION: FRFE resulted in a significant improvement of memory, as its treatment attenuated the scopolamine-induced anterograde and retrograde amnesia dose-dependently. Further, cyproheptadine pretreatment significantly reversed the anti-amnesic effect of FRFE. CONCLUSION: FRFE has anti-amnesic activity against scopolamine-induced amnesia, in a dose-dependent manner. Inhibition of the anti-amnesic effect of FRFE by cyproheptadine substantiates the involvement of serotonergic pathways for its activity.


Asunto(s)
Amnesia Anterógrada/prevención & control , Amnesia Retrógrada/prevención & control , Ficus/química , Nootrópicos/uso terapéutico , Fitoterapia , Extractos Vegetales/uso terapéutico , Escopolamina/toxicidad , Amnesia Anterógrada/inducido químicamente , Amnesia Retrógrada/inducido químicamente , Animales , Reacción de Prevención/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Femenino , Frutas/química , India , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Medicina Tradicional , Memoria/efectos de los fármacos , Ratones , Nootrópicos/administración & dosificación , Nootrópicos/química , Extractos Vegetales/administración & dosificación , Extractos Vegetales/química , Tiempo de Reacción/efectos de los fármacos , Antagonistas de la Serotonina/farmacología , Agonistas de Receptores de Serotonina/administración & dosificación , Agonistas de Receptores de Serotonina/química , Agonistas de Receptores de Serotonina/uso terapéutico , Factores de Tiempo
4.
J Neurosci ; 25(27): 6343-9, 2005 Jul 06.
Artículo en Inglés | MEDLINE | ID: mdl-16000624

RESUMEN

We used a free-recall paradigm to establish a behavioral index of the retrograde and anterograde interference of emotion with episodic memory encoding. In two experiments involving 78 subjects, we show that negatively valenced items elicit retrograde amnesia, whereas positively valenced items elicit retrograde hypermnesia. These data indicate item valence is critical in determining retrograde amnesia and retrograde hypermnesia. In contrast, we show that item arousal induces an anterograde amnesic effect, consistent with the idea that a valence-evoked arousal mechanism compromises anterograde episodic encoding. Randomized double-blind administration of the beta-adrenoceptor antagonist propranolol compared with the selective norepinephrine (NE) reuptake-inhibitor reboxetine, and placebo, demonstrated that the magnitude of this emotional amnesia and hypermnesia can be upregulated and downregulated as a function of emotional arousal and central NE signaling. We conclude that a differential processing of emotional arousal and valence influences how the brain remembers and forgets.


Asunto(s)
Amnesia Anterógrada/fisiopatología , Amnesia Retrógrada/fisiopatología , Emociones/fisiología , Memoria a Corto Plazo/fisiología , Recuerdo Mental/fisiología , Norepinefrina/fisiología , Inhibidores de Captación Adrenérgica/farmacología , Inhibidores de Captación Adrenérgica/uso terapéutico , Antagonistas Adrenérgicos beta/farmacología , Antagonistas Adrenérgicos beta/uso terapéutico , Adulto , Amnesia Anterógrada/etiología , Amnesia Anterógrada/prevención & control , Amnesia Anterógrada/psicología , Amnesia Retrógrada/etiología , Amnesia Retrógrada/prevención & control , Amnesia Retrógrada/psicología , Amígdala del Cerebelo/efectos de los fármacos , Amígdala del Cerebelo/fisiopatología , Nivel de Alerta/fisiología , Método Doble Ciego , Emociones/efectos de los fármacos , Femenino , Humanos , Masculino , Memoria a Corto Plazo/efectos de los fármacos , Recuerdo Mental/efectos de los fármacos , Morfolinas/farmacología , Morfolinas/uso terapéutico , Estimulación Luminosa , Propranolol/farmacología , Propranolol/uso terapéutico , Reboxetina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...